Medicines Australia Limited - Revocation and Substitution - A91316 - A91320

Date lodged: 
4 July 2012
Status: 
Completed
Outcome: 
Granted on 20 December 2012

Summary

On 4 July 2012 Medicines Australia Limited applied for reauthorisation (application for revocation and substitution) for its Code of Conduct Edition 17. The Code of Conduct sets standards for the advertising and promotion of pharmaceutical products.

On 20 December 2012 the ACCC issued a determination granting reauthorisation for a period of two years.

A copy of the ACCC's determination is available by following the links below.

Applicant(s)

  • Medicines Australia Limited

Authorisation number(s)

  • A91316
  • A91317
  • A91318
  • A91319
  • A91320

Applications

Document title Date
Code of Conduct Edition 17 ( PDF 348.46 KB ) 13 Sep 2012
Received ( PDF 2.58 MB ) 4 Jul 2012

Decisions

Document title Date
Final Determination ( PDF 578.38 KB ) 20 Dec 2012
Draft Determination ( PDF 483.72 KB ) 26 Oct 2012

ACCC correspondence

Document title Date
ACCC to Interested Parties re Final Determination ( PDF 96.65 KB ) 20 Dec 2012
ACCC to Applicant re Final Determination ( PDF 95.78 KB ) 20 Dec 2012
ACCC to Dr Ken Harvey re Material Excluded from Public Register ( PDF 93.42 KB ) 3 Dec 2012
ACCC to Applicant re Material Excluded from Public Register ( PDF 93.93 KB ) 21 Nov 2012
ACCC to Applicant re Material Excluded from Public Register ( PDF 92.93 KB ) 16 Nov 2012
ACCC to Interested Parties re Draft Determination ( PDF 86.64 KB ) 26 Oct 2012
ACCC to Applicant re Draft Determination ( PDF 87.97 KB ) 26 Oct 2012
ACCC to interested parties re consultation process ( PDF 124.72 KB ) 9 Jul 2012
ACCC to applicant re consultation process ( PDF 47.73 KB ) 9 Jul 2012
Show all documents (6 more)

Submissions - before draft decision

Document title Date
An Interested Party ( PDF 30.66 KB ) 16 Sep 2012
Code of Conduct Edition 17 ( PDF 348.46 KB ) 13 Sep 2012
Applicant ( PDF 105.45 KB ) 13 Sep 2012
Applicant ( PDF 247.8 KB ) 24 Aug 2012
Dept. Health and Ageing ( PDF 149.73 KB ) 9 Aug 2012
Merck Sharp & Dohme (Australia) Pty Ltd ( PDF 38.4 KB ) 31 Jul 2012
An Interested Party ( PDF 957.99 KB ) 30 Jul 2012
Australian Medical Association ( PDF 111.14 KB ) 30 Jul 2012
Consumers Health Forum of Australia ( PDF 280.16 KB ) 30 Jul 2012
Roche ( PDF 444.76 KB ) 30 Jul 2012
Dr Agnes Vitry ( PDF 28.99 KB ) 30 Jul 2012
Friends of Science and Medicine ( PDF 166.44 KB ) 30 Jul 2012
Professor Anthony J Smith ( PDF 21.01 KB ) 30 Jul 2012
Professor Philip Morris ( PDF 31.71 KB ) 30 Jul 2012
Glenys Nall ( PDF 22.19 KB ) 30 Jul 2012
Choice ( PDF 142.76 KB ) 30 Jul 2012
Bruce Arnold ( PDF 72.1 KB ) 30 Jul 2012
Generic Medicines Industry Association ( PDF 504.01 KB ) 27 Jul 2012
The Pharmacy Guild of Australia ( PDF 46.24 KB ) 27 Jul 2012
Sanofi ( PDF 92.9 KB ) 26 Jul 2012
Dr Paul Atkins ( PDF 13.24 KB ) 26 Jul 2012
Dr Robert Purssey ( PDF 32.79 KB ) 26 Jul 2012
Ray Moynihan ( PDF 85.66 KB ) 26 Jul 2012
Jon Jureidini ( PDF 47.28 KB ) 25 Jul 2012
David Meller ( PDF 35.92 KB ) 25 Jul 2012
GlaxoSmithKline ( PDF 420.75 KB ) 24 Jul 2012
ACT Health ( PDF 44.42 KB ) 24 Jul 2012
Professor Mooney ( PDF 34.99 KB ) 20 Jul 2012
Ian Haines ( PDF 536.89 KB ) 17 Jul 2012
Professor Faunce ( PDF 187.57 KB ) 10 Jul 2012
Chris Del Mar ( PDF 75.24 KB ) 10 Jul 2012
Show all documents (28 more)

Submissions - after draft decision

Document title Date
Dr Ken Harvey & Ors ( PDF 29.38 KB ) 30 Nov 2012
Applicant ( PDF 1.75 MB ) 19 Nov 2012
Australian Medical Association ( PDF 107.54 KB ) 15 Nov 2012
Pfizer ( PDF 627.42 KB ) 13 Nov 2012
Dr Ken Harvey ( PDF 66.06 KB ) 12 Nov 2012
Dr Ken Harvey ( PDF 24.71 KB ) 12 Nov 2012
Applicant ( PDF 171.61 KB ) 9 Nov 2012
Generic Medicines Industry Association ( PDF 196.41 KB ) 9 Nov 2012
Prof Philip Morris ( PDF 21.62 KB ) 6 Nov 2012
Consumers Health Forum ( PDF 1.68 MB ) 6 Nov 2012
Prof Gavin Mooney ( PDF 9.44 KB ) 31 Oct 2012
Show all documents (8 more)

Pre-decision conferences

Document title Date
Pre-decision Conference Minutes ( PDF 92.3 KB ) 12 Nov 2012
Certificate of Pre-decision Conference ( PDF 35.55 KB ) 12 Nov 2012
GlaxoSmithKline ( PDF 73.92 KB ) 2 Nov 2012
ACCC to Interested Parties re Pre-decision Conference ( PDF 91.61 KB ) 31 Oct 2012
ACCC to Applicant re Pre-decision Conference ( PDF 90.33 KB ) 31 Oct 2012
Prof Philip Morris to ACCC re Request for Pre-Decision Conference ( PDF 10.69 KB ) 27 Oct 2012
Show all documents (3 more)